- CME Group and Nasdaq (NDAQ) have extended their partnership for Nasdaq-100 futures and options licenses through 2039.
- CME Group reports a 22% year-over-year increase in average daily volume (ADV) for Nasdaq-100 futures and options.
- Micro E-mini Nasdaq-100 futures witnessed a 39% rise in Q2 ADV.
CME Group and Nasdaq (NDAQ) have announced a significant extension of their exclusive licensing agreement, allowing CME Group to continue offering futures and options on futures based on the Nasdaq-100 and other Nasdaq indexes through the year 2039. This partnership reinforces CME Group's position as the operator of the largest equity index futures complex globally.
The Nasdaq-100 futures, which were initially launched in 1996 with E-mini Nasdaq-100 futures launched by CME Group in 1999, are among the most traded equity index futures contracts in the world, with more than 2.8 billion contracts traded. This extension builds upon nearly three decades of collaboration between the two entities.
According to CME Group, the average daily volume (ADV) for their Nasdaq-100 futures and options on futures complex has more than doubled since their last license extension agreement in 2019. For the year-to-date period, the ADV has surged to over 2.5 million contracts, reflecting a 22% increase compared to the previous year. Notably, the Micro E-mini Nasdaq-100 futures recorded a 39% increase in Q2 ADV, reaching 1.3 million contracts.
CME Group remains committed to providing seamless access to its products, enabling global market participants to effectively manage risk or gain exposure to large non-financial companies listed on Nasdaq. This collaboration underscores the robust derivatives ecosystem that supports investor confidence and market integrity in the equity markets.
